Product peg-derivatives -peptide-pegs

Home > products > peg-derivatives > peptide-pegs

Catalog	name	Description	price
R-M1-8337	Fmoc-NH-PEG11-CH2COOH	Fmoc-NH-PEG11-CH2COOH is a PEG linker containing an Fmoc-protected amine and a terminal carboxylic acid. The hydrophilic PEG spacer increases solubility in aqueous media. The Fmoc group can be deprotected under basic condition to obtain the free amine which can be used for further conjugations. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. Reagent grade, for research purpose.	price>
R-M1-8338	Fmoc-NH-PEG12-CH2COOH,cas:2291257-76-4	Fmoc-NH-PEG12-CH2COOH is a PEG linker containing an Fmoc-protected amine and a terminal carboxylic acid. The hydrophilic PEG spacer increases solubility in aqueous media. The Fmoc group can be deprotected under basic condition to obtain the free amine which can be used for further conjugations. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. Reagent grade, for research purpose.	price>
R-M1-8342	mPEG2K-TK-CRHSQMTVTSRL	The mPEG2000-TK-CP05 modified exosomes can serve as effective delivery platforms for enhanced photodynamic/chemical cancer treatment.CP05 peptide (CRHSQMTVTSRL) can be used to study injectable thermosensitive hydrogel for bone regeneration.	price>
R-M1-8349	NHS-PEG5K-cRGDfK	NHS-PEG5K-cRGDfK is a derivative of peptide peg.	price>
R-M1-8391	SH-PEG5K-RVRRCK	The PEG chain provides water solubility and can enhance the molecules stability and bioavailability.The peptide sequence RVRRCK can be derived from a protein and may serve as a targeting moiety for specific cells or tissues that express a receptor for this sequence. The use of SH-PEG5K-RVRRCK can facilitate drug delivery, improve therapeutic efficacy,and enhance the performance of diagnostic assays or imaging agents.	price>
R-M1-8411	NH2-PEG2000-FAEKFKEAVKDYFAKFWD	NH2-PEG2000-FAEKFKEAVKDYFAKFWD is a molecule consisting of a polyethylene glycol (PEG) chain with 2000 repeating units, an amine group, and a peptide sequence (FAEKFKEAVKDYFAKFWD) attached to the amine group. The PEG chain provides water solubility and can increase the molecules circulation time in vivo. The peptide sequence is derived from a protein and can be used as a targeting moiety for specific cells or tissues that express a receptor for the sequence. The sequence also contains specific amino acids that can potentially inhibit protease enzymes. The use of NH2-PEG2000-FAEKFKEAVKDYFAKFWD can lead to improvements in drug delivery systems, targeting of cancer cells, and other biomedical applications.	price>
R-M1-8414	mpeg2000-RVG29	MPEG2000-RVG29 represents a conjugate or complex formation between MPEG2000 and RVG29. This conjugation allows for the specific targeting of neuronal cells expressing the nicotinic acetylcholine receptor, opening up possibilities for applications such as targeted drug delivery to the central nervous system, delivery of therapeutic agents to specific brain regions, or non-invasive imaging of neuronal activity.	price>
R-M1-8416	DBCO-PEG4-R9-Asn Pro Gly Tyr	DBCO-PEG4-R9-Asn Pro Gly Tyr may be used to create a bioconjugate or nanocarrier system for targeted drug delivery or cellular imaging applications. The DBCO group allows for click chemistry-based conjugation, the PEG4 spacer improves solubility and reduces steric hindrance, the R9 peptide aids in cellular uptake, and the Asn-Pro-Gly-Tyr amino acid sequence may have specific targeting or functional properties depending on the application.	price>
R-M1-8423	mPEG2000-CGPLGVRGK-WKLFKKILKVL	When combined together, mPEG2000-CGPLGVRGK-WKLFKKILKVL likely represents a peptide-PEG conjugate where the PEG chain provides stability and solubility, while the peptide sequences contribute to specific functionalities such as cellular penetration and angiostatic effects. This type of construct can be utilized in drug delivery systems, particularly for targeted therapy or as carriers for therapeutic agents.	price>
R-M1-8426	Alendronic Acid-PEG2K-iRGD	Alendronic Acid-PEG2K-iRGD is a compound designed to potentially improve the targeted delivery and efficacy of alendronic acid in the treatment of tumors or cancer-related conditions by incorporating PEG2K and iRGD peptide targeting.	price>

...